Immune responses and protection against experimental challenge after vaccination of bison with Brucella abortus strain RB51 or RB51 overexpressing superoxide dismutase and glycosyltransferase genes.
about
Vaccination with Brucella abortus recombinant in vivo-induced antigens reduces bacterial load and promotes clearance in a mouse model for infectionOntology-based Brucella vaccine literature indexing and systematic analysis of gene-vaccine association network.Immune responses and protection against experimental Brucella suis biovar 1 challenge in nonvaccinated or B. abortus strain RB51-vaccinated cattle.Recent advances in Brucella abortus vaccinesA Leptospira borgpetersenii serovar Hardjo vaccine induces a Th1 response, activates NK cells, and reduces renal colonization.Immune responses of bison and efficacy after booster vaccination with Brucella abortus strain RB51.Comparison of abortion and infection after experimental challenge of pregnant bison and cattle with Brucella abortus strain 2308.Immune responses and safety after dart or booster vaccination of bison with Brucella abortus strain RB51.Efficacy of dart or booster vaccination with strain RB51 in protecting bison against experimental Brucella abortus challengeVaccination of Elk (Cervus canadensis) with Brucella abortus Strain RB51 Overexpressing Superoxide Dismutase and Glycosyltransferase Genes Does Not Induce Adequate Protection against Experimental Brucella abortus Challenge.Comparison between Immunization Routes of Live Attenuated Salmonella Typhimurium Strains Expressing BCSP31, Omp3b, and SOD of Brucella abortus in Murine Model.Progress in Brucella vaccine development.Protection efficacy of the Brucella abortus ghost vaccine candidate lysed by the N-terminal 24-amino acid fragment (GI24) of the 36-amino acid peptide PMAP-36 (porcine myeloid antimicrobial peptide 36) in murine modelsAnalyses of Brucella pathogenesis, host immunity, and vaccine targets using systems biology and bioinformatics.Biosafety considerations for in vivo work with risk group 3 pathogens in large animals and wildlife in North America.Development and trial of vaccines against Brucella.Mathematical analysis of the transmission dynamics of brucellosis among bison
P2860
Q33848963-546F8ED9-BF67-4148-B6EE-BDA183D828A2Q34003852-6F39C413-3F22-4F08-A9EC-2237F88FEE85Q34431972-8E86A3D0-62B3-4EED-B28B-3E80FA99476DQ34484123-9D082FF4-2BF3-4F90-8939-7D71269A5120Q35066339-DCFA5727-9538-45BF-93F4-9AC75FB6F4BDQ35221165-E74BC13D-892F-49AB-BFDA-C7A89CFCF1BAQ35598227-AFC10879-4B6F-4256-8B99-FF188E396EA9Q35940665-1CAD721D-7686-4B88-BD85-9EF27A66D2F4Q36017756-64575C8F-01F6-4F9B-B970-8A3FC4A99E49Q36564404-5B51BE14-0F62-4541-A7F0-EA47D9F6E9D5Q36814216-F03B78B4-83A8-4407-9B6A-BC978604E17FQ36883753-0DD8D53B-881C-4CCB-9633-7B15536B838CQ37393824-1EB7809E-2AB2-478E-843D-073E4923D70FQ38037536-0516349D-4BBD-4A56-A590-C1A8DA353A23Q38071318-DED377CA-F19F-4254-B935-DCB8C053C94EQ40072449-8A20F8B3-C905-4C9E-9A04-D64F4BE93371Q57710240-87BAE641-5556-487B-B46B-6D1374B113B6
P2860
Immune responses and protection against experimental challenge after vaccination of bison with Brucella abortus strain RB51 or RB51 overexpressing superoxide dismutase and glycosyltransferase genes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Immune responses and protectio ...... and glycosyltransferase genes.
@en
Immune responses and protectio ...... and glycosyltransferase genes.
@nl
type
label
Immune responses and protectio ...... and glycosyltransferase genes.
@en
Immune responses and protectio ...... and glycosyltransferase genes.
@nl
prefLabel
Immune responses and protectio ...... and glycosyltransferase genes.
@en
Immune responses and protectio ...... and glycosyltransferase genes.
@nl
P2093
P2860
P356
P1476
Immune responses and protectio ...... and glycosyltransferase genes.
@en
P2093
G G Schurig
N N Sriranganathan
P2860
P304
P356
10.1128/CVI.00419-08
P577
2009-01-28T00:00:00Z